Cargando…
Dexmedetomidine as adjunct in awake craniotomy – improvement or not?
BACKGROUND: Over the last decade, awake craniotomy for tumor resection has become a standard to maximize tumor resection and minimize the risk of permanent neurological deficits. Different techniques and medication regimes have been tested for this procedure. Until today there is no consensus on the...
Autores principales: | Raimann, Florian J., Adam, Elisabeth H., Strouhal, Ulrich, Zacharowski, Kai, Seifert, Volker, Forster, Marie-Therese |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173139/ https://www.ncbi.nlm.nih.gov/pubmed/32090308 http://dx.doi.org/10.5114/ait.2020.93043 |
Ejemplares similares
-
Use of dexmedetomidine infusion in anaesthesia for awake craniotomy
por: Kallapur, Basavaraj G, et al.
Publicado: (2012) -
Awake craniotomy with dexmedetomidine during resection of brain tumours located in eloquent regions
por: Lechowicz-Głogowska, Bogusława Ewa, et al.
Publicado: (2022) -
Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil
por: Prontera, Andrea, et al.
Publicado: (2017) -
Inflammatory Profile of Awake Function-Controlled Craniotomy and Craniotomy under General Anesthesia
por: Klimek, Markus, et al.
Publicado: (2009) -
Anesthetic considerations for awake craniotomy: case report
por: Freitas, Cassiano Hamacek de, et al.
Publicado: (2017)